Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-12-2012 | Research

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam

Authors: Tran Tinh Hien, Nguyen Thanh Thuy-Nhien, Nguyen Hoan Phu, Maciej F Boni, Ngo Viet Thanh, Nguyen Thuy Nha-Ca, Le Hong Thai, Cao Quang Thai, Pham Van Toi, Phung Duc Thuan, Le Thanh Long, Le Thanh Dong, Laura Merson, Christiane Dolecek, Kasia Stepniewska, Pascal Ringwald, Nicholas J White, Jeremy Farrar, Marcel Wolbers

Published in: Malaria Journal | Issue 1/2012

Login to get access

Abstract

Background

By 2009, there were worrying signs from western Cambodia that parasitological responses to artesunate-containing treatment regimens for uncomplicated Plasmodium falciparum malaria were slower than elsewhere which suggested the emergence of artemisinin resistance. Vietnam shares a long land border with Cambodia with a large number of migrants crossing it on a daily basis. Therefore, there is an urgent need to investigate whether there is any evidence of a change in the parasitological response to the artemisinin derivatives in Vietnam.

Methods

From August 2010 to May 2011, a randomized controlled clinical trial in uncomplicated falciparum malaria was conducted to compare two doses of artesunate (AS) (2mg/kg/day versus 4 mg/kg/day for three days) followed by dihydroartemisinin-piperaquine (DHA-PPQ) and a control arm of DHA-PPQ. The goal was characterization of the current efficacy of artesunate in southern Vietnam. The primary endpoint of this study was the parasite clearance half-life; secondary endpoints included the parasite reduction ratios at 24 and 48 hours and the parasite clearance time.

Results

166 patients were recruited into the study. The median parasite clearance half-lives were 3.54 (AS 2mg/kg), 2.72 (AS 4mg/kg), and 2.98 hours (DHA-PPQ) (p=0.19). The median parasite-reduction ratio at 24 hours was 48 in the AS 2mg/kg group compared with 212 and 113 in the other two groups, respectively (p=0.02). The proportions of patients with a parasite clearance time of >72 hours for AS 2mg/kg, AS 4mg/kg and DHA-PPQ were 27%, 27%, and 22%, respectively. Early treatment failure occurred in two (4%) and late clinical failure occurred in one (2%) of the 55 patients in the AS 2mg/kg group, as compared with none in the other two study arms. The PCR-corrected adequate clinical and parasitological response (APCR) rates in the three groups were 94%, 100%, and 100% (p=0.04).

Conclusions

This study demonstrated faster P. falciparum parasite clearance in southern Vietnam than in western Cambodia but slower clearance in comparison with historical data from Vietnam. Further studies to determine whether this represents the emergence of artemisinin resistance in this area are needed. Currently, the therapeutic response to DHA-PPQ remains satisfactory in southern Vietnam.

Trial registration

NTC01165372
Appendix
Available only for authorised users
Literature
1.
go back to reference Hien TT: An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam. Trans R Soc Trop Med Hyg. 1994, 88 (Suppl 1): S7-S8.CrossRefPubMed Hien TT: An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam. Trans R Soc Trop Med Hyg. 1994, 88 (Suppl 1): S7-S8.CrossRefPubMed
2.
go back to reference Hien TT, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, Farrar J: Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet. 2004, 363: 18-22. 10.1016/S0140-6736(03)15163-X.CrossRef Hien TT, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, Farrar J: Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet. 2004, 363: 18-22. 10.1016/S0140-6736(03)15163-X.CrossRef
3.
go back to reference Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056/NEJMoa0808859.PubMedCentralCrossRefPubMed Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009, 361: 455-467. 10.1056/NEJMoa0808859.PubMedCentralCrossRefPubMed
4.
go back to reference Noedl H, Socheat D, Satimai W: Artemisinin-resistant malaria in Asia. N Engl J Med. 2009, 361: 540-541. 10.1056/NEJMc0900231.CrossRefPubMed Noedl H, Socheat D, Satimai W: Artemisinin-resistant malaria in Asia. N Engl J Med. 2009, 361: 540-541. 10.1056/NEJMc0900231.CrossRefPubMed
5.
go back to reference Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, Socheat D, Ariey F, Wongsrichanalai C: Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J. 2009, 8: 10-10.1186/1475-2875-8-10.PubMedCentralCrossRefPubMed Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, Socheat D, Ariey F, Wongsrichanalai C: Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J. 2009, 8: 10-10.1186/1475-2875-8-10.PubMedCentralCrossRefPubMed
6.
go back to reference Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F: Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One. 2009, 4: e4551-10.1371/journal.pone.0004551.PubMedCentralCrossRefPubMed Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F: Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One. 2009, 4: e4551-10.1371/journal.pone.0004551.PubMedCentralCrossRefPubMed
7.
go back to reference Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012, 379: 1960-1966. 10.1016/S0140-6736(12)60484-X.PubMedCentralCrossRefPubMed Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012, 379: 1960-1966. 10.1016/S0140-6736(12)60484-X.PubMedCentralCrossRefPubMed
9.
go back to reference Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ: In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010, 201: 570-579. 10.1086/650301.PubMedCentralCrossRefPubMed Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ: In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010, 201: 570-579. 10.1086/650301.PubMedCentralCrossRefPubMed
11.
go back to reference Bereczky S, Martensson A, Gil JP, Farnert A: Short report: Rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. AmJTrop Med Hyg. 2005, 72: 249-251. Bereczky S, Martensson A, Gil JP, Farnert A: Short report: Rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. AmJTrop Med Hyg. 2005, 72: 249-251.
12.
go back to reference Moll K, Ljungström I, Perlmann H, Scherf A, Wahlgren M: MR4/ATCC (Manassas, Virginia and BioMalPar (Paris, France)). Methods in malaria research. 2008 Moll K, Ljungström I, Perlmann H, Scherf A, Wahlgren M: MR4/ATCC (Manassas, Virginia and BioMalPar (Paris, France)). Methods in malaria research. 2008
15.
go back to reference Flegg JA, Guerin PJ, White NJ, Stepniewska K: Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011, 10: 339-10.1186/1475-2875-10-339.PubMedCentralCrossRefPubMed Flegg JA, Guerin PJ, White NJ, Stepniewska K: Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011, 10: 339-10.1186/1475-2875-10-339.PubMedCentralCrossRefPubMed
16.
go back to reference Phu NH, Tuan PQ, Day N, Mai NT, Chau TT, Chuong LV, Sinh DX, White NJ, Farrar J, Hien TT: Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malar J. 2010, 9: 97-10.1186/1475-2875-9-97.PubMedCentralCrossRefPubMed Phu NH, Tuan PQ, Day N, Mai NT, Chau TT, Chuong LV, Sinh DX, White NJ, Farrar J, Hien TT: Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malar J. 2010, 9: 97-10.1186/1475-2875-9-97.PubMedCentralCrossRefPubMed
17.
go back to reference Fraley C, Raftery AE, Murphy TB, Scrucca L: mclust Version 4 for R: Normal Mixture Modeling for Model-Based Clustering, Classification, and Density Estimation Technical Report No. 597. 2012, University of Washington: Department of Statistics Fraley C, Raftery AE, Murphy TB, Scrucca L: mclust Version 4 for R: Normal Mixture Modeling for Model-Based Clustering, Classification, and Density Estimation Technical Report No. 597. 2012, University of Washington: Department of Statistics
18.
go back to reference Anderson TJ, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, Socheat D, Das D, Chotivanich K, Day NP, White NJ, Dondorp AM: High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis. 2010, 201: 1326-1330. 10.1086/651562.PubMedCentralCrossRefPubMed Anderson TJ, Nair S, Nkhoma S, Williams JT, Imwong M, Yi P, Socheat D, Das D, Chotivanich K, Day NP, White NJ, Dondorp AM: High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis. 2010, 201: 1326-1330. 10.1086/651562.PubMedCentralCrossRefPubMed
19.
go back to reference Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJ: A major genome region underlying artemisinin resistance in malaria. Science. 2012, 336: 79-82. 10.1126/science.1215966.PubMedCentralCrossRefPubMed Cheeseman IH, Miller BA, Nair S, Nkhoma S, Tan A, Tan JC, Al Saai S, Phyo AP, Moo CL, Lwin KM, McGready R, Ashley E, Imwong M, Stepniewska K, Yi P, Dondorp AM, Mayxay M, Newton PN, White NJ, Nosten F, Ferdig MT, Anderson TJ: A major genome region underlying artemisinin resistance in malaria. Science. 2012, 336: 79-82. 10.1126/science.1215966.PubMedCentralCrossRefPubMed
21.
go back to reference Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu JDuong S, Fairhurst RM: Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012, 12: 851-858. 10.1016/S1473-3099(12)70181-0.PubMedCentralCrossRefPubMed Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu JDuong S, Fairhurst RM: Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012, 12: 851-858. 10.1016/S1473-3099(12)70181-0.PubMedCentralCrossRefPubMed
22.
go back to reference O'Riordan S, Hien TT, Miles K, Allen A, Quyen NN, Hung NQ, Anh do Q, Tuyen LN, Khoa DB, Thai CQ, Triet DM, Phu NH, Dunstan S, Peto T, Clegg J, Farrar J, Weatherall D: Large scale screening for haemoglobin disorders in southern Vietnam: implications for avoidance and management. Br J Haematol. 2010, 150: 359-364. 10.1111/j.1365-2141.2010.08237.x.CrossRefPubMed O'Riordan S, Hien TT, Miles K, Allen A, Quyen NN, Hung NQ, Anh do Q, Tuyen LN, Khoa DB, Thai CQ, Triet DM, Phu NH, Dunstan S, Peto T, Clegg J, Farrar J, Weatherall D: Large scale screening for haemoglobin disorders in southern Vietnam: implications for avoidance and management. Br J Haematol. 2010, 150: 359-364. 10.1111/j.1365-2141.2010.08237.x.CrossRefPubMed
23.
go back to reference Hien TT: Anti-malarial drug treatment in Vietnam. PhD Thesis. 2004, Open University UK: Oxford University Clinical Research Unit Hien TT: Anti-malarial drug treatment in Vietnam. PhD Thesis. 2004, Open University UK: Oxford University Clinical Research Unit
24.
go back to reference Thanh NV, Toan TQ, Cowman AF, Casey GJ, Phuc BQ, Tien NT, Hung NM, Biggs BA: Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998–2009. Malar J. 2010, 9: 181-10.1186/1475-2875-9-181.PubMedCentralCrossRefPubMed Thanh NV, Toan TQ, Cowman AF, Casey GJ, Phuc BQ, Tien NT, Hung NM, Biggs BA: Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998–2009. Malar J. 2010, 9: 181-10.1186/1475-2875-9-181.PubMedCentralCrossRefPubMed
25.
go back to reference Teuscher F, Gatton ML, Chen N, Peters J, Kyle DE, Cheng Q: Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis. 2010, 202: 1362-1368. 10.1086/656476.PubMedCentralCrossRefPubMed Teuscher F, Gatton ML, Chen N, Peters J, Kyle DE, Cheng Q: Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis. 2010, 202: 1362-1368. 10.1086/656476.PubMedCentralCrossRefPubMed
26.
27.
go back to reference Boni MF, Smith DL, Laxminarayan R: Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci U S A. 2008, 105: 14216-14221. 10.1073/pnas.0804628105.PubMedCentralCrossRefPubMed Boni MF, Smith DL, Laxminarayan R: Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci U S A. 2008, 105: 14216-14221. 10.1073/pnas.0804628105.PubMedCentralCrossRefPubMed
28.
go back to reference Hastings I: How artemisinin-containing combination therapies slow the spread of anti-malarial drug resistance. Trends Parasitol. 2011, 27: 67-72. 10.1016/j.pt.2010.09.005.CrossRefPubMed Hastings I: How artemisinin-containing combination therapies slow the spread of anti-malarial drug resistance. Trends Parasitol. 2011, 27: 67-72. 10.1016/j.pt.2010.09.005.CrossRefPubMed
29.
go back to reference Editorial: New estimates of malaria deaths: concern and opportunity. Lancet. 2012, 379: 385-10.1016/S0140-6736(12)60169-X. Editorial: New estimates of malaria deaths: concern and opportunity. Lancet. 2012, 379: 385-10.1016/S0140-6736(12)60169-X.
30.
go back to reference Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012, 379: 413-431. 10.1016/S0140-6736(12)60034-8.CrossRefPubMed Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012, 379: 413-431. 10.1016/S0140-6736(12)60034-8.CrossRefPubMed
Metadata
Title
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam
Authors
Tran Tinh Hien
Nguyen Thanh Thuy-Nhien
Nguyen Hoan Phu
Maciej F Boni
Ngo Viet Thanh
Nguyen Thuy Nha-Ca
Le Hong Thai
Cao Quang Thai
Pham Van Toi
Phung Duc Thuan
Le Thanh Long
Le Thanh Dong
Laura Merson
Christiane Dolecek
Kasia Stepniewska
Pascal Ringwald
Nicholas J White
Jeremy Farrar
Marcel Wolbers
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-355

Other articles of this Issue 1/2012

Malaria Journal 1/2012 Go to the issue